Good evening :)
Place Order
Add to Watchlist

Lotus Eye Hospital and Institute Ltd

LOTUSEYE Share Price

68.156.02% (+3.87)

LOTUSEYE Share Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹133 cr, stock is ranked 2,666
High RiskStock is 3.37x as volatile as Nifty

LOTUSEYE Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹133 cr, stock is ranked 2,666
High RiskStock is 3.37x as volatile as Nifty

LOTUSEYE Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
278.502.25
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
49.276.300.54%

LOTUSEYE Analyst Ratings & Forecast

Detailed Forecast 
Forecast data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

See Detailed Forecast

LOTUSEYE Company Profile

Lotus Eye Hospital and Institute Limited is engaged in the provision of healthcare services. The Company is engaged in the field of ophthalmology (eye) and its related operation.

LOTUSEYE Similar Stocks (Peers)

Compare with peers 
PE Ratio
103.18
1Y Return
40.77%
Buy Reco %
73.68
PE Ratio
104.32
1Y Return
4.63%
Buy Reco %
86.21
PE Ratio
81.40
1Y Return
62.58%
Buy Reco %
100.00
PE Ratio
41.94
1Y Return
31.75%
Buy Reco %
66.67
PE Ratio
90.81
1Y Return
9.42%
Buy Reco %
71.43
Compare with Peers

LOTUSEYE Forecasts

Price

Revenue

Earnings

LOTUSEYE

Income

Balance Sheet

Cash Flow

LOTUSEYE Income Statement

Industry refers to the sub-sector this company belongs to.
Lower than Industry Revenue Growth
A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 4.83%, vs industry avg of 10.01%

Decreasing Market Share
Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share decreased from 0.11% to 0.08%

Lower than Industry Net Income
Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 32.59%, vs industry avg of 42.91%

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue31.7134.6738.9339.1141.4833.2039.8048.1949.5250.13
Raw Materialssubtract8.4010.2710.896.186.114.765.696.937.0544.59
Power & Fuel Costsubtract0.960.981.111.241.220.960.851.031.38
Employee Costsubtract5.807.007.788.498.176.826.988.529.25
Selling & Administrative Expensessubtract5.125.526.336.386.514.065.185.966.17
Operating & Other expensessubtract6.866.897.5612.9215.2912.1414.2916.9117.73
Depreciation/Amortizationsubtract4.443.443.373.062.502.332.502.983.734.72
Interest & Other Itemssubtract0.160.150.180.210.240.140.210.200.200.30
Taxes & Other Itemssubtract-0.12-0.03-0.04-0.080.390.421.111.571.100.04
EPS0.040.220.840.340.500.751.441.971.400.23
DPS0.000.500.500.000.000.500.500.500.000.00
Payout ratio0.002.310.590.000.000.660.350.250.000.00

LOTUSEYE Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2021

Annual report

PDF

Investor Presentation

Feb 9PDF
FY 2022

Annual report

PDF

Investor Presentation

Jul 3PDF
 

LOTUSEYE Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CareHospitals & Diagnostic Centres

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Lotus Eye Hospital and Institute Ltd45.942.25
Max Healthcare Institute Ltd103.1812.980.13%
Apollo Hospitals Enterprise Ltd104.3212.810.25%
Fortis Healthcare Ltd81.405.700.15%

LOTUSEYE Stock Price Comparison

Compare LOTUSEYE with any stock or ETF
Compare LOTUSEYE with any stock or ETF
LOTUSEYE
Loading...

LOTUSEYE Shareholdings

LOTUSEYE Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

LOTUSEYE Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

LOTUSEYE Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding40.14%0.00%0.04%0.00%59.82%

Mar 2024

Jun 2024

Sep 2024

Dec 2024

LOTUSEYE Shareholding History

SepDec '23MarJunSepDec '240.00%0.00%0.00%0.00%0.00%0.00%

LOTUSEYE Insider Trades & Bulk Stock Deals

Loading...

smallcases containing LOTUSEYE stock

Looks like this stock is not in any smallcase yet.

LOTUSEYE Events

LOTUSEYE Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

LOTUSEYE Upcoming Dividends

No upcoming dividends are available

LOTUSEYE Past Dividends

Cash Dividend

Ex DateEx DateSep 18, 2023

Final
Final | Div/Share: ₹0.50

Dividend/Share

0.50

Ex DateEx Date

Sep 18, 2023

Cash Dividend

Ex DateEx DateSep 8, 2022

Final
Final | Div/Share: ₹0.50

Dividend/Share

0.50

Ex DateEx Date

Sep 8, 2022

Cash Dividend

Ex DateEx DateSep 8, 2021

Final
Final | Div/Share: ₹0.50

Dividend/Share

0.50

Ex DateEx Date

Sep 8, 2021

Cash Dividend

Ex DateEx DateSep 14, 2018

Final
Final | Div/Share: ₹0.50

Dividend/Share

0.50

Ex DateEx Date

Sep 14, 2018

Cash Dividend

Ex DateEx DateAug 2, 2017

Final
Final | Div/Share: ₹0.50

Dividend/Share

0.50

Ex DateEx Date

Aug 2, 2017

LOTUSEYE Stock News & Opinions

Earnings
Lotus Eye Hospital & Institute reports standalone net loss of Rs 0.24 crore in the December 2024 quarter

Net loss of Lotus Eye Hospital & Institute reported to Rs 0.24 crore in the quarter ended December 2024 as against net profit of Rs 0.66 crore during the previous quarter ended December 2023. Sales rose 1.83% to Rs 12.25 crore in the quarter ended December 2024 as against Rs 12.03 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales12.2512.03 2 OPM %6.4513.13 - PBDT0.881.89 -53 PBT-0.430.91 PL NP-0.240.66 PL Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
Lotus Eye Hospital & Institute standalone net profit declines 88.24% in the September 2024 quarter

Net profit of Lotus Eye Hospital & Institute declined 88.24% to Rs 0.10 crore in the quarter ended September 2024 as against Rs 0.85 crore during the previous quarter ended September 2023. Sales rose 1.41% to Rs 12.91 crore in the quarter ended September 2024 as against Rs 12.73 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales12.9112.73 1 OPM %8.9114.22 - PBDT1.342.07 -35 PBT0.111.18 -91 NP0.100.85 -88 Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Lotus Eye Hospital & Institute to discuss results

Lotus Eye Hospital & Institute will hold a meeting of the Board of Directors of the Company on 12 November 2024Powered by Capital Market - Live

4 months agoCapital Market - Live
Earnings
Lotus Eye Hospital & Institute standalone net profit declines 55.07% in the June 2024 quarter

Net profit of Lotus Eye Hospital & Institute declined 55.07% to Rs 0.62 crore in the quarter ended June 2024 as against Rs 1.38 crore during the previous quarter ended June 2023. Sales rose 2.55% to Rs 12.89 crore in the quarter ended June 2024 as against Rs 12.57 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales12.8912.57 3 OPM %12.9618.93 - PBDT1.922.64 -27 PBT0.861.91 -55 NP0.621.38 -55 Powered by Capital Market - Live

7 months agoCapital Market - Live
Corporate
Lotus Eye Hospital & Institute to convene AGM

Lotus Eye Hospital & Institute announced that the 27th Annual General Meeting (AGM) of the company will be held on 13 August 2024.Powered by Capital Market - Live

8 months agoCapital Market - Live

BRIEF-Lotus Eye Hospital And Institute - Names Kavetha Sundaramoorthy As Chairman - Investing.com India

4 years agoInvesting.com

BRIEF-Lotus Eye Hospital And Institute Ltd - Approved Appointment Of K.S. Ramalingam As CEO - Investing.com India

4 years agoInvesting.com

Frequently asked questions

  1. What is the share price of Lotus Eye Hospital and Institute Ltd (LOTUSEYE) today?

    The share price of LOTUSEYE as on 27th March 2025 is ₹68.15. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Lotus Eye Hospital and Institute Ltd (LOTUSEYE) share?

    The past returns of Lotus Eye Hospital and Institute Ltd (LOTUSEYE) share are
    • Past 1 week: 8.93%
    • Past 1 month: 2.02%
    • Past 3 months: 1.84%
    • Past 6 months: -14.28%
    • Past 1 year: 19.14%
    • Past 3 years: 15.61%
    • Past 5 years: 182.78%

  3. What are the peers or stocks similar to Lotus Eye Hospital and Institute Ltd (LOTUSEYE)?
  4. What is the market cap of Lotus Eye Hospital and Institute Ltd (LOTUSEYE) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Lotus Eye Hospital and Institute Ltd (LOTUSEYE) is ₹133.68 Cr as of 27th March 2025.

  5. What is the 52 week high and low of Lotus Eye Hospital and Institute Ltd (LOTUSEYE) share?

    The 52-week high of Lotus Eye Hospital and Institute Ltd (LOTUSEYE) is ₹90.98 and the 52-week low is ₹52.35.

  6. What is the PE and PB ratio of Lotus Eye Hospital and Institute Ltd (LOTUSEYE) stock?

    The P/E (price-to-earnings) ratio of Lotus Eye Hospital and Institute Ltd (LOTUSEYE) is 45.94. The P/B (price-to-book) ratio is 2.25.

  7. Which sector does Lotus Eye Hospital and Institute Ltd (LOTUSEYE) belong to?

    Lotus Eye Hospital and Institute Ltd (LOTUSEYE) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.

  8. How to buy Lotus Eye Hospital and Institute Ltd (LOTUSEYE) shares?

    You can directly buy Lotus Eye Hospital and Institute Ltd (LOTUSEYE) shares on Tickertape. Simply sign up, connect your demat account and place your order.